Prof Tibor Kovács speaks to ecancer at BGICC 2019 in Cairo about sentinel lymph node biopsy following neoadjuvant chemotherapy.

He explains that, in the neoadjuvant setting, sentinel lymph node biopsy can still be performed and has several advantages such as reducing complications from axillary lymph node clearance.

Prof Kovács explains that studies have shown that SLNB can be performed after neoadjuvant chemotherapy despite patients having a more advanced disease and even with patients previously being node positive.